173 related articles for article (PubMed ID: 35120732)
1. Evidence and implementation gaps in management of sentinel node-positive melanoma in the United States.
Broman KK; Richman J; Bhatia S
Surgery; 2022 Jul; 172(1):226-233. PubMed ID: 35120732
[TBL] [Abstract][Full Text] [Related]
2. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Broman KK; Hughes TM; Bredbeck BC; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; O'shea K; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Hotz M; Farma JM; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley GM; Hui JYC; Been L; Kruijff S; Sinco B; Sarnaik AA; Sondak VK; Zager JS; Dossett LA;
Ann Surg; 2023 May; 277(5):e1106-e1115. PubMed ID: 35129464
[TBL] [Abstract][Full Text] [Related]
3. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
5. [Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].
Orion C; Dinulescu M; Dalac-Rat S; Giacchero D; Jouary T; Lebbé C; Leccia MT; Maubec E; Meyer N; Mortier L; Dupuy A;
Ann Dermatol Venereol; 2020 Jan; 147(1):9-17. PubMed ID: 31761496
[TBL] [Abstract][Full Text] [Related]
6. Observation policy for sentinel node metastasis of melanoma: Comparative study with completion lymph node dissection in Japanese patients.
Matsui Y; Sasaki J; Takatsuka S; Takenouchi T
J Dermatol; 2021 Aug; 48(8):1221-1228. PubMed ID: 33960497
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection.
Broman KK; Bettampadi D; Pérez-Morales J; Sun J; Kirichenko D; Carr MJ; Eroglu Z; Tarhini AA; Khushalani N; Schabath MB; Sarnaik A; Sondak VK; Zager JS
Ann Surg Oncol; 2021 Nov; 28(12):6978-6985. PubMed ID: 34363118
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy.
Farrow NE; Raman V; Williams TP; Nguyen KY; Tyler DS; Beasley GM
Ann Surg Oncol; 2020 Dec; 27(13):5121-5125. PubMed ID: 32314157
[TBL] [Abstract][Full Text] [Related]
10. The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma.
Hieken TJ; Kane JM; Wong SL
Ann Surg Oncol; 2019 Apr; 26(4):1028-1034. PubMed ID: 30284132
[TBL] [Abstract][Full Text] [Related]
11. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
12. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.
Wright FC; Souter LH; Kellett S; Easson A; Murray C; Toye J; McCready D; Nessim C; Ghazarian D; Hong NJL; Johnson S; Goldstein DP; Petrella T;
Curr Oncol; 2019 Aug; 26(4):e541-e550. PubMed ID: 31548823
[TBL] [Abstract][Full Text] [Related]
13. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Faries MB; Thompson JF; Cochran AJ; Andtbacka RH; Mozzillo N; Zager JS; Jahkola T; Bowles TL; Testori A; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; Wouters MWJM; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Rossi CR; Neves RI; Trocha SD; Wright F; Byrd DR; Matter M; Hsueh E; MacKenzie-Ross A; Johnson DB; Terheyden P; Berger AC; Huston TL; Wayne JD; Smithers BM; Neuman HB; Schneebaum S; Gershenwald JE; Ariyan CE; Desai DC; Jacobs L; McMasters KM; Gesierich A; Hersey P; Bines SD; Kane JM; Barth RJ; McKinnon G; Farma JM; Schultz E; Vidal-Sicart S; Hoefer RA; Lewis JM; Scheri R; Kelley MC; Nieweg OE; Noyes RD; Hoon DSB; Wang HJ; Elashoff DA; Elashoff RM
N Engl J Med; 2017 Jun; 376(23):2211-2222. PubMed ID: 28591523
[TBL] [Abstract][Full Text] [Related]
14. Necessity and time interval of regional lymph node dissection for malignant melanoma with positive sentinel lymph node biopsy: Does the time interval between sentinel lymph node biopsy and completion of lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study - a commentary.
Chai J; Mei Z; Chen Y
Int J Surg; 2023 Jul; 109(7):2143-2144. PubMed ID: 37288561
[No Abstract] [Full Text] [Related]
15. Current management of patients with melanoma who are found to be sentinel node-positive.
Nijhuis AAG; Spillane AJ; Stretch JR; Saw RPM; Menzies AM; Uren RF; Thompson JF; Nieweg OE
ANZ J Surg; 2020 Apr; 90(4):491-496. PubMed ID: 31667924
[TBL] [Abstract][Full Text] [Related]
16. National Practice Patterns in the Management of the Regional Lymph Node Basin After Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma.
Sharon CE; Straker RJ; Li EH; Karakousis GC; Miura JT
Ann Surg Oncol; 2022 Dec; 29(13):8456-8464. PubMed ID: 36006494
[TBL] [Abstract][Full Text] [Related]
17. A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 era.
Downs JS; Subramaniam S; Henderson MA; Paton E; Spillane AJ; Mathy JA; Gyorki DE
J Surg Oncol; 2021 Dec; 124(8):1544-1550. PubMed ID: 34406652
[TBL] [Abstract][Full Text] [Related]
18. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
Persa OD; Knuever J; Mauch C; Schlaak M
J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
[TBL] [Abstract][Full Text] [Related]
19. Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients.
Ogata D; Tanese K; Nakamura Y; Otsuka M; Namikawa K; Funakoshi T; Yoshikawa S; Tsutsui K; Nakama K; Jinnai S; Kiyohara Y; Takahashi A; Yamazaki N
Int J Clin Oncol; 2021 Dec; 26(12):2338-2346. PubMed ID: 34545533
[TBL] [Abstract][Full Text] [Related]
20. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
